1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Lung Transplantation-Pipeline Insights, 2017

Lung Transplantation-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Lung Transplantation-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Lung Transplantation. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Lung Transplantation. DelveInsight’s Report also assesses the Lung Transplantation therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Lung Transplantation
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Lung Transplantation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Lung Transplantation and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Lung Transplantation-Pipeline Insights, 2017
Illustrative

- Lung Transplantation Overview
- Lung Transplantation Pipeline Therapeutics
- Lung Transplantation Therapeutics under Development by Companies
- Lung Transplantation Filed and Phase III Products
- Comparative Analysis
- Lung Transplantation Phase II Products
- Comparative Analysis
- Lung Transplantation Phase I and IND Filed Products
- Comparative Analysis
- Lung Transplantation Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Lung Transplantation - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Lung Transplantation - Discontinued Products
- Lung Transplantation - Dormant Products
- Companies Involved in Therapeutics Development for Lung Transplantation
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Lung Transplantation, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Lung Transplantation Assessment by Monotherapy Products
- Lung Transplantation Assessment by Combination Products
- Lung Transplantation Assessment by Route of Administration
- Lung Transplantation Assessment by Stage and Route of Administration
- Lung Transplantation Assessment by Molecule Type
- Lung Transplantation Assessment by Stage and Molecule Type
- Lung Transplantation Therapeutics - Discontinued Products
- Lung Transplantation Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Lung Transplantation, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Lung Transplantation Assessment by Monotherapy Products
- Lung Transplantation Assessment by Combination Products
- Lung Transplantation Assessment by Route of Administration
- Lung Transplantation Assessment by Stage and Route of Administration
- Lung Transplantation Assessment by Molecule Type
- Lung Transplantation Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Photopheresis Products Market: Overview The photopheresis products market is mainly driven by growing Graft versus host disease conditions globally. Furthermore the rising coverage of healthcare ...

Global Organ and Tissue Transplantation - Medical Equipment & Supplies

Global Organ and Tissue Transplantation - Medical Equipment & Supplies

  • $ 4950
  • Industry report
  • November 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Organ and Tissue Transplantation in number of organs transplanted. The Global and regional markets (except the US) for Organ and Tissue Transplantation in ...

Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Lung Transplant Rejection Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.